ASND
Ascendis Pharma A/SstockNASDAQ
Market OpenNov 16, 2026 10:39:09 AM EST
274.68USD-0.256%(-0.71)113,990
ASND Financials
In Q3 FY 2026 (ended ), Ascendis Pharma A/S (ASND) reported revenue of €369.66M, net income of €73.97M, operating cash flow of €188.79M, and assets of €2.43B in EUR (filed ).
Loading financial statements…